Circulatory pattern of cytokines, adipokines and bone markers in postmenopausal women with low BMD

References

• Melton LJ 3rd, Chrischilles EA, Cooper C, Lane AW, Riggs BL. Perspective. How many women have osteoporosis? J Bone Miner Res. 1992;7(9):1005–1010. doi:10.1002/jbmr.56500709021414493
   PubMed Web of Science ®Google Scholar
• Malutan AM, Dan M, Nicolae C, Carmen M. Proinflammatory and anti-inflammatory cytokine changes related to menopause. Prz Menopauzalny. 2014;13(3):162–168. doi:10.5114/pm.2014.4381826327849
   PubMedGoogle Scholar
• Faienza MF, Ventura A, Marzano F, Cavallo L. Postmenopausal osteoporosis: the role of immune system cells. Clin Dev Immunol. 2013;2013:575936. doi:10.1155/2013/65742423762093
   PubMedGoogle Scholar
• Takayanagi H. Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol. 2009;5(12):667–676. doi:10.1038/nrrheum.2009.21719884898
   PubMed Web of Science ®Google Scholar
• Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7(1):33–42. doi:10.1038/nrrheum.2011.221119608
   PubMed Web of Science ®Google Scholar
• Pietschmann P, Mechtcheriakova D, Meshcheryakova A, Föger-Samwald U, Ellinger I. Immunology of osteoporosis: a mini-review. Gerontology. 2015;62(2):128–137. doi:10.1159/00043109126088283
   PubMed Web of Science ®Google Scholar
• Lubkowska A, Dobek A, Mieszkowski J, Garczynski W, Chlubek D. Adiponectin as a biomarker of osteoporosis in postmenopausal women: controversies. Dis Markers. 2014;2014:1–14. doi: 10.1155/2014/975178.
   Web of Science ®Google Scholar
• Mohiti-Ardekani J, Soleymani-Salehabadi H, Owlia MB, Mohiti A. Relationships between serum adipocyte hormones (adiponectin, leptin, resistin), bone mineral density and bone metabolic markers in osteoporosis patients. J Bone Miner Metab. 2014;32(4):400–404. doi:10.1007/s00774-013-0511-424052207
   PubMed Web of Science ®Google Scholar
• Biver E, Salliot C, Combescure C, et al. Influence of adipokines and Ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. Journal Clin Endocrinol Metab. 2011;96(9):2703–2713. doi:10.1210/jc.2011-004721778223
   PubMed Web of Science ®Google Scholar
• Jürimäe J, Jürimäe T, Leppik A, Kums T. The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women. J Bone Miner Metab. 2008;26(6):618–623. doi:10.1007/s00774-008-0861-518979162
   PubMed Web of Science ®Google Scholar
• Mpalaris V, Anagnostis P, Anastasilakis AD, Goulis DG, Doumas A, Iakovou I. Serum leptin, adiponectin and ghrelin concentrations in post-menopausal women: is there an association with bone mineral density? Maturitas. 2016;88:32–36.27105694
   PubMed Web of Science ®Google Scholar
• Tanna N, Patel K, Moore AE, Dulnoan D, Edwards S, Hampson G. The relationship between circulating adiponectin, leptin and vaspin with bone mineral density (BMD), arterial calcification and stiffness: a cross-sectional study in post-menopausal women. J Endocrinol Invest. 2017;40(12):1345–1353. doi:10.1007/s40618-017-0711-128646476
   PubMed Web of Science ®Google Scholar
• Vosoberg K, Tillmann V, Tamm AL, Jurimae T, Maasalu K, Jurimae J. Adipocytokine and ghrelin levels in relation to bone mineral density in prepubertal rhythmic gymnasts entering puberty: a 3-year follow-up study. Eur J Appl Physiol. 2016;116(4):831–839. doi:10.1007/s00421-016-3338-626879077
   PubMed Web of Science ®Google Scholar
• Hlaing TT, Compston JE. Biochemical markers of bone turnover–uses and limitations. Ann Clin Biochem. 2014;51(2):189–202.
   PubMed Web of Science ®Google Scholar
• Johansson H, Odén A, Kanis JA, et al. A meta-analysis of reference markers of bone turnover for prediction of fracture. Calcif Tissue Int. 2014;94(5):560–567. doi:10.1007/s00223-014-9842-y24590144
   PubMed Web of Science ®Google Scholar
• Bergmann P, Body JJ, Boonen S, et al. Evidence‐based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian bone club. Int J Clin Pract. 2009;63(1):19–26. doi:10.1111/j.1742-1241.2008.01911.x19125989
   PubMed Web of Science ®Google Scholar
• Vasikaran S, Eastell R, Bruyère O, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2011;22(2):391–420. doi:10.1007/s00198-010-1501-121184054
   PubMed Web of Science ®Google Scholar
• Morris H, Eastell R, Jorgesen N, et al. Clinical usefulness of bone turnover marker concentrations in osteoporosis. Clin Chimica Acta. 2017;467:34–41.
   PubMed Web of Science ®Google Scholar
• Manolagas SC. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 2010;31(3):266–300. doi:10.1210/er.2009-002420051526
   PubMed Web of Science ®Google Scholar
• Almeida M, Laurent MR, Dubois V, et al. Estrogens and androgens in skeletal physiology and pathophysiology. Physiol Rev. 2017;97(1):135–187. doi:10.1152/physrev.00033.201527807202
   PubMed Web of Science ®Google Scholar
• Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh YM. A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag. 2018;14:2029–2049. doi:10.2147/TCRM.S13800030464484
   PubMed Web of Science ®Google Scholar
• Khosla S, Melton LJ 3rd, Riggs BL. Clinical review 144: estrogen and the male skeleton. J Clin Endocrinol Metab. 2002;87(4):1443–1450. doi:10.1210/jcem.87.4.841711932262
   PubMed Web of Science ®Google Scholar
• Carani C, Qin K, Simoni M, et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med. 1997;337(2):91–95. doi:10.1056/NEJM1997071033702049211678
   PubMed Web of Science ®Google Scholar
• Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS. Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab. 2003;88(1):204–210. doi:10.1210/jc.2002-02103612519853
   PubMed Web of Science ®Google Scholar
• Hofbauer LC, Hicok KC, Chen D, Khosla S. Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells. Eur J Endocrinol. 2002;147(2):269–273. doi:10.1530/eje.0.147026912153751
   PubMed Web of Science ®Google Scholar
• Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology. 1999;140(9):4367–4370. doi:10.1210/endo.140.9.713110465311
   PubMed Web of Science ®Google Scholar
• Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 2000;21(2):115–137.10782361
   PubMed Web of Science ®Google Scholar
• Azizieh F, Raghupathy R, Shehab D, Al-Jarallah K, Gupta R. Cytokine profiles in osteoporosis suggest a proresorptive bias. Menopause. 2017;24(9):1057–1064. doi:10.1097/GME.000000000000088528609384
   PubMed Web of Science ®Google Scholar
• Rauner M, Sipos W, Pietschmann P. Osteoimmunology. Int Arch Allergy Immunol. 2007;143(1):31–48. doi:10.1159/00009822317191007
   PubMed Web of Science ®Google Scholar
• Azizieh FY, Al Jarallah K, Shehab D, Gupta R, Dingle K, Raghupathy R. Patterns of circulatory and peripheral blood mononuclear cytokines in rheumatoid arthritis. Rheumatol Int. 2017;37(10):1727–1734. doi:10.1007/s00296-017-3774-628726020
   PubMed Web of Science ®Google Scholar
• Burska A, Boissinot M, Ponchel F. Cytokines as biomarkers in rheumatoid arthritis. Mediators Inflamm. 2014;2014:545493. doi:10.1155/2014/54549324733962
   PubMed Web of Science ®Google Scholar
• Sahin G, Ozturk C, Bagis S, Cimen OB, Erdogan C. Correlation of serum cytokine levels with axial bone mineral density. Singapore Med J. 2002;43(11):576–578.12680527
   PubMedGoogle Scholar
• Zhang J, Fu Q, Ren Z, et al. Changes of serum cytokines-related Th1/Th2/Th17 concentration in patients with postmenopausal osteoporosis. Gynecological Endocrinol. 2015;31(3):183–190. doi:10.3109/09513590.2014.975683
   PubMed Web of Science ®Google Scholar
• Whiteside TL. Cytokines and cytokine measurements in a clinical laboratory. Clin Diagn Lab Immunol. 1994;1(3):257–260.7496959
   PubMedGoogle Scholar
• Tworoger SS, Hankinson SE. Collection, processing, and storage of biological samples in epidemiologic studies: sex hormones, carotenoids, inflammatory markers, and proteomics as examples. Cancer Epidemiol Biomarkers Prev. 2006;15(9):1578–1581. doi:10.1158/1055-9965.EPI-06-062916985015
   PubMed Web of Science ®Google Scholar
• Hosnijeh FS, Krop EJ, Portengen L, et al. Stability and reproducibility of simultaneously detected plasma and serum cytokine levels in asymptomatic subjects. Biomarkers. 2010;15(2):140–148. doi:10.3109/1354750090334057019848603
   PubMed Web of Science ®Google Scholar
• Wang Q-P, Yang L, Li X-P, et al. Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand. Bone. 2012;51(3):515–523. doi:10.1016/j.bone.2012.05.01122634178
   PubMed Web of Science ®Google Scholar
• Ozkurt B, Ozkurt ZN, Altay M, Aktekin CN, Caglayan O, Tabak Y. The relationship between serum adiponectin level and anthropometry, bone mass, osteoporotic fracture risk in postmenopausal women. Eklem Hastalik Cerrahisi. 2009;20(2):78–84.19619110
   PubMed Web of Science ®Google Scholar
• Wu N, Wang Q-P, Li H, Wu X-P, Sun Z-Q, Luo X-H. Relationships between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese women. Clin Chimica Acta. 2010;411(9):771–775. doi:10.1016/j.cca.2010.02.064
   PubMed Web of Science ®Google Scholar
• Miyatani Y, Yasui T, Uemura H, et al. Associations of circulating adiponectin with estradiol and monocyte chemotactic protein-1 in postmenopausal women. Menopause. 2008;15(3):536–541. doi:10.1097/gme.0b013e31815c85ed18347511
   PubMed Web of Science ®Google Scholar
• Tworoger SS, Mantzoros C, Hankinson SE. Relationship of plasma adiponectin with sex hormone and insulin‐like growth factor levels. Obesity. 2007;15(9):2217–2224. doi:10.1038/oby.2007.53517890489
   PubMed Web of Science ®Google Scholar
• Siemińska L, Cichoń-Lenart A, Kajdaniuk D, et al. [Sex hormones and adipocytokines in postmenopausal women]. Polski merkuriusz lekarski. 2006;20(120):727–730.17007280
   PubMedGoogle Scholar
• Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol Series A. 2014;69(Suppl 1):S4–S9. doi:10.1093/gerona/glu057
   PubMed Web of Science ®Google Scholar
• Riggs BL, Melton LJ, Robb RA, et al. A population‐based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Mineral Res. 2008;23(2):205–214. doi:10.1359/jbmr.071020
   PubMed Web of Science ®Google Scholar
• Parfitt A. Osteoporosis: 50 years of change, mostly in the right direction In: Osteoporosis and Bone Biology. Compston J, Ralston S, editors. London: The State of the Art International Medical Press; 2000:1–13.
   Google Scholar